Kelly McCall, PhD
Professor; Associate Chair
Academic and Research Center
Diabetes Institute
Specialty Medicine
Athens
Education:
- Molecular & Cellular Biology (PhD), Ohio University, 2003
- Biological Sciences (BS), Ohio University, 1997
Expertise:
- Toll-like receptors
- Diabetes mellitus, Type 1 and 2
- Chronic inflammation
- Phenylmethimazole (C10)
- Cancer
- Atherosclerosis
- Wnt5a
- Novel therapeutics
- Nonalcoholic fatty liver disease
- Interferon regulatory factor-3
- Autoimmunity
- Autoimmune diseases
- Chronic inflammatory diseases
- Obesity
- Mouse models of disease
Summary of Work:
I study molecular pathways involved in autoimmune/inflammatory diseases (AIDs) & utilize this knowledge to develop novel therapeutics. My work established aberrant toll-like receptor (TLR) expression & signaling in non-immune cells is a key mediator of AIDs; work that initiated a paradigm shift.
Links:
View My Work in the National Center for Biotechnology Information (NCBI)